Enara Bio
Beth joined Enara Bio in March 2020, bringing over 12 years’ experience across research and development in project management and operational leadership.
Prior to joining Enara Bio, Beth was a Group Leader in Infectious Diseases at Immunocore. In this role, she successfully led the introduction of project management and operational processes into the group and managed the progression of early-phase programs from research into clinical development. Previously, Beth was Project Manager for Phase 1 vaccine clinical trials in HIV and Hepatitis C at the University of Oxford. She also brings expertise in analytical method development and validation, which she gained as a Study Manager at Covance Laboratories in the UK.
Beth holds an MSci in Biochemistry and Biological Chemistry from the University of Nottingham and a DPhil in Biochemistry from the University of Oxford.
This person is not in any teams
This person is not in any offices
Enara Bio
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.